Expert Opinion On Drug Discovery

Journal Title：Expert Opinion On Drug Discovery

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology

Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug

The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.

《药物发现专家意见》（ISSN 1746-0441 [印刷版]，1746-045X [电子版]）是一本 MEDLINE 索引、同行评审的国际期刊，发表有关药物发现过程中涉及的新技术的评论文章，从而带来新的线索并降低流失率。每篇文章都包含作者自己对未来发展范围的专家意见。

编辑欢迎：

评论涵盖化学信息学；生物信息学；检测开发；新型筛选技术；体外/体内模型；基于结构的药物设计；系统生物学

药物案例历史，研究特定药物的临床前和临床开发所涉及的步骤

读者包括医疗保健和制药行业的科学家和管理人员、学术制药科学家和其他密切相关的专业人士，他们希望通过临床前水平的优化来提高其候选药物的成功率。

Expert Opinion On Drug Discovery创刊于2006年，由Informa Healthcare出版商出版，收稿方向涵盖医学 - 药学全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 较慢,6-12周 ，影响因子指数6，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。